Evidence map›Paper›PMID 31396300›Full record

ArticleOxidative medicine and cellular longevity2019

Reactive Oxygen Species Are Involved in the Development of Gastric Cancer and Gastric Cancer-Related Depression through ABL1-Mediated Inflammation Signaling Pathway.

Tianhe Huang, Fuling Zhou, Xiaohan Yuan, Tian Yang, Xuan Liang, Yu Wang, Honglei Tu, Jiantong Chang, Kejun Nan, Yongchang Wei

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Energy metabolism: a new target for gastric cancer treatment.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Microorganisms · 2023
    Review
  12. Protective Effect of the Phycobiliproteins fromPlants (Basel, Switzerland) · 2023
    Article
  13. Review
  14. A Bioinformatic Analysis: The Overexpression and Prognostic Potential ofInternational journal of general medicine · 2022
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Tianhe HuangDepartment of Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061 Shaanxi Province, China.ORCID https://orcid.org/0000-0002-2737-4016
Fuling ZhouDepartment of Hematology, Zhongnan Hospital of Wuhan University, 430071 Hubei, China.ORCID https://orcid.org/0000-0003-0982-0382
Xiaohan YuanDepartment of Oncology, The First Affiliated Hospital of Xinxiang Medical University, Weihui, 453100 Henan Province, China.
Tian YangDepartment of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, 430071 Hubei, China.
Xuan LiangDepartment of Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061 Shaanxi Province, China.
Yu WangDepartment of Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061 Shaanxi Province, China.
Honglei TuDepartment of Hematology, Zhongnan Hospital of Wuhan University, 430071 Hubei, China.
Jiantong ChangDepartment of General Surgery, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004 Shaanxi Province, China.
Kejun NanDepartment of Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061 Shaanxi Province, China.ORCID https://orcid.org/0000-0002-3783-117X
Yongchang WeiDepartment of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, 430071 Hubei, China.ORCID https://orcid.org/0000-0001-7205-4663
First Affiliated Hospital of Xi'an Jiaotong University · CNWuhan University · CNFirst Affiliated Hospital of Xinxiang Medical University · CNSecond Affiliated Hospital of Xi'an Jiaotong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe mechanisms of crosstalk between depression and gastric cancer (GC) remain ill defined. Given that reactive oxygen species (ROS) is involved in the pathophysiology of both GC and depression, we try to explore the activities of ROS in the development of GC and GC-related depression.

methods110 patients with newly diagnosed GC were recruited in our study. The clinical characteristics of these patients were recorded. Inflammation and oxidative stress markers were detected by ELISA. The depression status of patients with GC was assessed during follow-up. The association between ROS, ABL1, and inflammation factors was evaluated in H

resultsDepression was correlated with poor prognosis of patients with GC. GC patients with depression were under a high level of oxidative status as well as dysregulated inflammation. In the CMS-induced GC PDX mice model, CMS could facilitate the development of GC. Additionally, tumor bearing could induce depressive-like behaviors of mice. With the treatment of ROS, the activities of ABL1 and inflammatory signaling were enhanced both in vitro and in vivo, and blocking the activities of ABL1 inhibited inflammatory signaling.

conclusionsROS-activated ABL1 mediates inflammation through regulating NF-

Indexed as

Signal Transduction8-Hydroxy-2'-DeoxyguanosineAnimalsAntineoplastic AgentsBehavior, AnimalCell Line, TumorCell MovementDepressionDisease Models, AnimalEpithelial-Mesenchymal TransitionHumansImatinib MesylateInflammation MediatorsMaleMiceMice, Nude8-Hydroxy-2'-DeoxyguanosineAntineoplastic AgentsImatinib MesylateInflammation MediatorsProto-Oncogene Proteins c-ablReactive Oxygen Species

Identifiers

PMID31396300
PMCPMC6664690
OpenAlexW2956190082

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.